Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B

被引:71
作者
Sprengers, D
van der Molen, RG
Kusters, JG
Hansen, B
Niesters, HGM
Schalm, SW
Janssen, HLA [1 ]
机构
[1] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Erasmus MC Univ Med Ctr, Dept Virol, Rotterdam, Netherlands
关键词
liver; fine needle aspiration biopsy; viral hepatitis; intrahepatic immune response;
D O I
10.1002/jmv.20576
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
Based on virological and biochemical parameters patients with chronic hepatitis B virus (HBV) are divided into distinct clinical phases: the immunetolerance phase, the immune-clearance phase, and the inactive carrier state. Unclear is whether these phases have characteristic intrahepatic immune responses. The composition of liverderived lymphocytes in patients with chronic HBV infection was studied. In 47 patients the composition of liver-derived lymphocytes was analyzed by flow cytometry of fine needle aspiration biopsies of the liver. The proportion natural killer (NK) cells in the liver was significantly higher in immune-tolerant than in immune-clearance patients and inactive carriers. No differences were found in proportion CD4+ T-cells and CD8+ T-cells, in these phases. However, when patients in the immune-clearance phase, with similar alanine transaminase (ALT), were grouped according to viral load, the proportion CD8+ T-cells was higher in those with high viral load. In contrast, the proportion CD4+T-cells was increased in patients with low HBV-DNA. These differences were absent in the peripheral blood (PB). Intrahepatic HBV-specific CD8+T-cells were mainly found in immune-clearance patients with low viral load. In conclusion, clear differences in the intrahepatic cellular infiltrate were found between the various clinical phases of chronic HBV infection. These findings are relevant to the design of new, individualized anti-viral strategies. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:561 / 568
页数:8
相关论文
共 34 条
[1]
Bertoletti A, 1997, HEPATOLOGY, V26, P1027, DOI 10.1002/hep.510260435
[2]
Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection [J].
Chu, CJ ;
Hussain, M ;
Lok, ASF .
HEPATOLOGY, 2002, 36 (06) :1408-1415
[3]
EASL International Concensus Conference on Hepatitis B -: 13-14 September, 2002 Geneva, Switzerland Consensus Statement (Long version) [J].
de Franchis, R ;
Hadengue, A ;
Lau, G ;
Lavanchy, D ;
Lok, A ;
McIntyre, N ;
Mele, A ;
Paumgartner, G ;
Pietrangelo, A ;
Rodés, J ;
Rosenberg, W ;
Valla, D .
JOURNAL OF HEPATOLOGY, 2003, 39 :S3-S25
[4]
FERRARI C, 1990, J IMMUNOL, V145, P3442
[5]
T-cell mediated immune responses in patients with hepatitis B e antigen negative chronic hepatitis B. [J].
Vassilopoulos, D ;
Rapti, I ;
Nikolaou, M ;
Hadziyannis, SJ .
HEPATOLOGY, 2001, 34 (04) :315A-315A
[6]
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised [J].
Janssen, HLA ;
van Zonneveld, M ;
Senturk, H ;
Zeuzem, S ;
Akarca, US ;
Cakaloglu, Y ;
Simon, C ;
So, TMJ ;
Gerken, G ;
de Man, RA ;
Niesters, HGM ;
Zondervan, P ;
Hansen, B ;
Schalm, SW .
LANCET, 2005, 365 (9454) :123-129
[7]
HEPATITIS-B VIRUS ANTIGEN-SPECIFIC T-CELL ACTIVATION IN PATIENTS WITH ACUTE AND CHRONIC HEPATITIS-B [J].
JUNG, MC ;
SPENGLER, U ;
SCHRAUT, W ;
HOFFMANN, R ;
ZACHOVAL, R ;
EISENBURG, J ;
EICHENLAUB, D ;
RIETHMULLER, G ;
PAUMGARTNER, G ;
ZIEGLERHEITBROCK, HWL ;
WILL, H ;
PAPE, GR .
JOURNAL OF HEPATOLOGY, 1991, 13 (03) :310-317
[8]
Natural killer T cell activation inhibits hepatitis B virus replication in vivo [J].
Kakimi, K ;
Guidotti, LG ;
Koezuka, Y ;
Chisari, FV .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :921-930
[9]
Peginterferon alone or with ribavirin enhances HCV-specific CD4+ T-helper 1 responses in patients with chronic hepatitis C [J].
Kamal, SM ;
Fehr, J ;
Roesler, B ;
Peters, T ;
Rasenack, JW .
GASTROENTEROLOGY, 2002, 123 (04) :1070-1083
[10]
Kane M., 1995, VACCINE S1, V13, P547